Weldon James
Family Medicine · Las Vegas, NVNPI 1053499970
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.6% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $779, 6.4 times the $122 reported in 2021.
Across 49 payments — averaging $33.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$240
- Viiv Healthcare Company$138
- AstraZeneca$134
- Idorsia Pharmaceuticals US Inc$125
- Vertex$120
- Novo Nordisk$110
- plus $755 from 23 others
What the payments were for
- Consulting fees$1207%
- Food & beverage$1,50193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 2 | $240 |
| Viiv Healthcare Company | 2 | $138 |
| AstraZeneca | 2 | $134 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Vertex | 1 | $120 |
| Novo Nordisk | 4 | $110 |
| Bayer | 4 | $70 |
| AbbVie | 2 | $65 |
| Dexcom, Inc. | 3 | $58 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Amgen | 3 | $48 |
| Shield Therapeutics Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Exact Sciences | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Viatris Specialty LLC | 1 | $24 |
| Gilead | 1 | $23 |
| Tolmar, Inc. | 1 | $22 |
| Mannkind Corporation | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Intra-sana Laboratories | 1 | $17 |
| Pfizer | 1 | $16 |
| Antares Pharma, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$129
- QUVIVIQ$125
- TRELEGY ELLIPTA$122
- APRETUDE$106
How this compares
$1,621 in reported general payments places this provider in the 75th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 17 | $661 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $209 |
| Pantoprazole Sodium | 12 | $160 |
| Tizanidine Hcl | 17 | $147 |
| Atorvastatin Calcium | 25 | $124 |
| Levothyroxine Sodium | 19 | $111 |
| Zolpidem Tartrate | 17 | $100 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $80 |
| Temazepam | 12 | $80 |
| Azithromycin | 15 | $78 |
| Alprazolam | 17 | $71 |
| Amlodipine Besylate | 14 | $66 |
| Lisinopril | 12 | $49 |
| Metformin Hcl | 12 | $23 |
| Meloxicam | 22 | $22 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Las Vegas
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Warren MagnusLas Vegas$70K
- Kimberly AdamsLas Vegas$51K
- Mandeep GillLas Vegas$24K
- Francis JimenezLas Vegas$20K
- Ryan HuangLas Vegas$18K
- Ma Francesca ChamianLas Vegas$17K
- Leo CapobiancoLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.